16-67174667-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6BP7BS2
The ENST00000564992.2(NOL3):āc.342G>Cā(p.Thr114=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000749 in 1,583,416 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00058 ( 0 hom., cov: 33)
Exomes š: 0.00077 ( 1 hom. )
Consequence
NOL3
ENST00000564992.2 synonymous
ENST00000564992.2 synonymous
Scores
1
12
Clinical Significance
Conservation
PhyloP100: 0.0190
Genes affected
NOL3 (HGNC:7869): (nucleolar protein 3) This gene encodes an anti-apoptotic protein that has been shown to down-regulate the enzyme activities of caspase 2, caspase 8 and tumor protein p53. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.028761).
BP6
Variant 16-67174667-G-C is Benign according to our data. Variant chr16-67174667-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 710884.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}. Variant chr16-67174667-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.019 with no splicing effect.
BS2
High AC in GnomAd4 at 89 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOL3 | NM_001276309.3 | c.342G>C | p.Thr114= | synonymous_variant | 3/4 | ENST00000564992.2 | NP_001263238.1 | |
NOL3 | XM_047434851.1 | c.528G>C | p.Thr176= | synonymous_variant | 4/5 | XP_047290807.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOL3 | ENST00000564992.2 | c.342G>C | p.Thr114= | synonymous_variant | 3/4 | 2 | NM_001276309.3 | ENSP00000457720 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000585 AC: 89AN: 152246Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
89
AN:
152246
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000536 AC: 118AN: 220318Hom.: 1 AF XY: 0.000498 AC XY: 60AN XY: 120592
GnomAD3 exomes
AF:
AC:
118
AN:
220318
Hom.:
AF XY:
AC XY:
60
AN XY:
120592
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000767 AC: 1097AN: 1431052Hom.: 1 Cov.: 32 AF XY: 0.000742 AC XY: 527AN XY: 709768
GnomAD4 exome
AF:
AC:
1097
AN:
1431052
Hom.:
Cov.:
32
AF XY:
AC XY:
527
AN XY:
709768
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000584 AC: 89AN: 152364Hom.: 0 Cov.: 33 AF XY: 0.000564 AC XY: 42AN XY: 74504
GnomAD4 genome
AF:
AC:
89
AN:
152364
Hom.:
Cov.:
33
AF XY:
AC XY:
42
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
67
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.332G>C (p.R111P) alteration is located in exon 3 (coding exon 2) of the NOL3 gene. This alteration results from a G to C substitution at nucleotide position 332, causing the arginine (R) at amino acid position 111 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N;N;N;N
PrimateAI
Benign
T
PROVEAN
Benign
N
Sift
Uncertain
D
Sift4G
Benign
T
Vest4
MVP
MPC
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at